237 related articles for article (PubMed ID: 3036431)
1. Differentiation of poliovirus type I isolates in the 1982 epidemic from Sabin-I strain by antigenic and temperature markers.
Lee CN; Kao CL; Lee CY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):80-8. PubMed ID: 3036431
[TBL] [Abstract][Full Text] [Related]
2. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
[TBL] [Abstract][Full Text] [Related]
3. Antigenic and biochemical characterization of poliovirus type 1 isolates of non-vaccine origin.
Hara M; Hagiwara A; Yoneyama T; Saito Y; Shimojo H
Microbiol Immunol; 1983; 27(12):1057-65. PubMed ID: 6328228
[TBL] [Abstract][Full Text] [Related]
4. Preliminary studies on antigenic variation of poliovirus using neutralizing monoclonal antibodies.
Guo R; Tang EH; Wang H; Yang XF; Liu MY; Qin HX; Li QH; Zhuang JY; Liu KM
J Gen Virol; 1987 Apr; 68 ( Pt 4)():989-94. PubMed ID: 3033136
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of molecular and antigenic characterization for intratypic differentiation (ITD) of poliovirus strains.
Adedeji AO; Okonko IO; Adu FD
J Med Virol; 2012 Dec; 84(12):1975-9. PubMed ID: 23080505
[TBL] [Abstract][Full Text] [Related]
6. Natural variation of poliovirus neutralization epitopes.
Crainic R; Couillin P; Blondel B; Cabau N; Boué A; Horodniceanu F
Infect Immun; 1983 Sep; 41(3):1217-25. PubMed ID: 6193066
[TBL] [Abstract][Full Text] [Related]
7. Mapping of type 1 poliovirus neutralization epitopes.
Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
[TBL] [Abstract][Full Text] [Related]
8. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
[TBL] [Abstract][Full Text] [Related]
9. Intratypic serodifferentiation of poliomyelitis virus strains by strain-specific antisera.
van Wezel AL; Hazendonk AG
Intervirology; 1979; 11(1):2-8. PubMed ID: 218891
[TBL] [Abstract][Full Text] [Related]
10. Neutralization epitope patterns of poliovirus strains isolated from paralytic cases.
Crainic R; Blondel B; Aubert-Combiescu A; Beytout D; Couillin P; Candrea A; Boué A; Horaud F
Dev Biol Stand; 1984; 57():165-70. PubMed ID: 6084607
[TBL] [Abstract][Full Text] [Related]
11. Antigenic and biochemical characterization of poliovirus type 1 isolates.
Hara M; Arita M; Yamazaki Z; Hagiwara A; Saito Y
Microbiol Immunol; 1987; 31(4):327-36. PubMed ID: 3039316
[TBL] [Abstract][Full Text] [Related]
12. Rapid and accurate identification of poliovirus strains used for vaccine production.
Nijst OE; Mouthaan JJ; Mekkes DR; Jusic E; van der Avoort HG; Metz B
J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540
[TBL] [Abstract][Full Text] [Related]
13. Antigenic variation among 173 strains of type 3 poliovirus isolated in Finland during the 1984 to 1985 outbreak.
Huovilainen A; Kinnunen L; Ferguson M; Hovi T
J Gen Virol; 1988 Aug; 69 ( Pt 8)():1941-8. PubMed ID: 2841408
[TBL] [Abstract][Full Text] [Related]
14. Antigenic analysis of polioviruses isolated from a child with agammaglobulinemia and paralytic poliomyelitis after Sabin vaccine administration.
Hara M; Saito Y; Komatsu T; Kodama H; Abo W; Chiba S; Nakao T
Microbiol Immunol; 1981; 25(9):905-13. PubMed ID: 6273701
[TBL] [Abstract][Full Text] [Related]
15. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
[TBL] [Abstract][Full Text] [Related]
16. Intratypic characterization of poliovirus type 1 isolates.
Deshpande JM; Dave KH
Indian J Med Res; 1991 Jul; 93():202-7. PubMed ID: 1660032
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.
Osterhaus AD; van Wezel AL; van Steenis B; Drost GA; Hazendonk TG
Intervirology; 1981; 16(4):218-24. PubMed ID: 6177658
[TBL] [Abstract][Full Text] [Related]
18. Determination of antigenic properties of vaccine derived poliovirus strains.
Pliaka V; Achilleos C; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonica C; Levidiotou-Stefanou S; Markoulatos P
Vaccine; 2010 Dec; 29(1):26-33. PubMed ID: 20974307
[TBL] [Abstract][Full Text] [Related]
19. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
[TBL] [Abstract][Full Text] [Related]
20. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
